Compare IMAB & JUNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
Junee Ltd is a holding company that operates through its subsidiary. It is an interior design and fit-out service provider in Hong Kong. It provides design, fit-out and repair and maintenance services for commercial and residential buildings. The design service includes both the consultation with its staff and the actual design work and it provides a specific conceptualized design with layout plans, detailed design drawings, advice relating to, and other items to be used to produce a preliminary design plan and quotation for clients' considerations. Fit-out works include installing protective materials to cover floors or walls, installing or constructing partition walls, and other electrical and wiring works. Repair and maintenance works include, among other things.